SEC Form 4 · accession 0001415889-18-001122
GridAI Technologies Corp. · GRDX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Daniel Dupret
Officer — CHIEF SCIENTIFIC OFFICER
Period of report
Jul 12, 2018
Accepted (ET)
Jul 18, 2018 · 11:57 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001604191
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jul 12, 2018 | A | 15,000 | — | A | 15,000 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| OptionsF2 | $3.04 | Jul 12, 2018 | A | 60,000 | A | — | Jun 28, 2023 | Common Stock | 60,000 | 60,000 | D |
Explanation of responses
- F1Represents grant of restricted stock. Shares shall vest in increments as follows: 7,500 shares upon the acceptance of a U.S. IND for MS1819, and 7,500 shares upon the the first CF patient dosed with MS1819 anywhere in the globe.
- F2Options with respect to 30,000 shares vest upon the acceptance of a U.S. IND for MS 1819, and the remaining 30,000 shares vest upon the the first CF patient dosed with MS1819 anywhere in the globe.